Prenatal Imaging and Therapy of Congenital Heart Disease


Introduction

Congenital abnormalities of the heart are the most common birth defects, occurring in approximately 8 of every 1,000 newborns. Approximately 25% of those in whom an abnormality is identified have critical congenital heart disease (CHD) with risk for significant perinatal compromise or death. Despite advances in imaging technology and technique, much CHD remains undetected until after birth. Fortunately, routine prenatal cardiac screening has evolved from single-frame acquisition imaging of the four-chamber heart view to include delineation of the outflow tracts, an addition which significantly improves CHD detection. Appropriate screening, when combined with fetal echocardiography when indicated, can readily identify and guide management for most cardiac abnormalities.

The complete fetal echocardiogram includes two-dimensional imaging, pulsed-wave and color Doppler interrogation, and M-mode imaging to completely assess fetal cardiac structure, function, and rhythm. Newer techniques may supplement the standard fetal echocardiogram and include tissue Doppler imaging, strain analysis, and three-dimensional imaging. This chapter reviews (1) normal fetal cardiac anatomy, physiology, and rhythm assessment; (2) common congenital cardiovascular lesions and heart rhythm abnormalities; and (3) indications for interventions for fetal heart disease and outcomes.

Fetal Physiology and Flow

An understanding of normal fetal cardiovascular anatomy and physiology is essential to interpretation of the fetal echocardiogram. The following are important differences between the fetal and postnatal circulation:

  • 1.

    The right ventricular output exceeds that of the left ventricle, resulting in a slightly larger right atrium, tricuspid valve, right ventricle, pulmonary valve, and main pulmonary artery when compared with their left-sided counterparts.

  • 2.

    The ductus venosus and foramen ovale are present; the ductus venosus shunts placental venous return to the right atrium and the foramen ovale directs this blood to the left atrium.

  • 3.

    The ductus arteriosus is present, allowing deoxygenated systemic venous return to bypass the branch pulmonary arteries and be directed to the descending aorta and placenta.

  • 4.

    The pulmonary vascular resistance is high, resulting in a relatively small proportion (approximately 10%) of the fetal cardiac output being directed toward the lungs.

Fetal Anatomic and Function Assessment

A complete fetal echocardiogram includes imaging of the atria, ventricles, atrioventricular and semilunar valves, foramen ovale, pulmonary veins, ductal and aortic arches, main and branch pulmonary arteries, and assessment of cardiac rhythm and function. Quantitative assessments of valve and vessel size should be compared with gestation-matched normative data. Pulsed-wave and color Doppler interrogation of each structure should be performed.

Visceral/Atrial Situs and Cardiac Position

Proper identification of situs at the beginning of a fetal echocardiogram is of paramount importance for framing the rest of the examination. The positions of the viscera within the abdomen and the heart within the thorax should be identified. In normal abdominal situs, the liver is right-sided and the stomach is left-sided. The normal position of the heart within the thorax is on the left (levocardia); additional possibilities are dextrocardia and mesocardia, wherein the majority of the cardiac mass is rightward or midline, respectively. The direction of the cardiac apex should also be identified. The apex normally points leftward, but rightward or posterior-anterior orientations are possible.

Once abdominal situs and cardiac position have been determined, delineation of atrial morphology should follow ( Fig. 70.1 ). The right atrium receives the coronary sinus and inferior vena cava, and its appendage is broad-based and triangular. The left atrium is characterized by the presence of septum primum, the “valve” of the foramen ovale and its appendage, which is slender and finger-like. The pulmonary veins usually connect to the left atrium, but there is significant variability of the pulmonary venous connections in CHD. Although “right” and “left” atria are typically in their usual right- and left-sided locations respectively, it is important to note that they may be inverted or ambiguous in nature.

Figure 70.1, Normal atrial and ventricular morphology on four-chamber view.

Right and Left Ventricles

The right and left ventricles should be identified by their distinguishing morphologic features. The right ventricle has a moderator band, attachments of its atrioventricular (tricuspid) valve to the ventricular septum (septophilic), an atrioventricular valve annulus apical to its left ventricular counterpart, and coarse trabeculations. The left ventricle, in contrast, has an atrioventricular (mitral) valve without attachments to the septum (septophobic), and appears smooth due to its fine trabeculations (see Fig. 70.1 ). As with the atria, although “right” and “left” ventricles are typically in their usual right- and left-sided locations, it is critical to note that other anatomic arrangements are possible, and ventricles may be left-right inverted (ventricular inversion) and, rarely, may assume a superior-inferior relationship. Ventricular function may be qualitatively assessed in both a four-chamber transverse view and a short-axis view. Calculation of left ventricular shortening fraction (left ventricular end diastolic—systolic/end diastolic diameter) and ejection fraction (left ventricular end diastolic—systolic/end diastolic volume) is possible with meticulous attention to imaging technique and precise measurements.

Atrioventricular and Semilunar Valves

The tricuspid and pulmonary valve annuli measure slightly larger than the mitral and aortic valves. Valves should be measured when they are maximally open: in diastole for the atrioventricular valves and systole for the semilunar valves. Significant size discrepancy between the two semilunar and/or atrioventricular valves should prompt careful evaluation for CHD. The mitral valve should be supported by two well-spaced ventricular papillary muscles easily identifiable on short-axis imaging. Color Doppler should readily identify any atrioventricular or semilunar valve regurgitation. Pulsed-wave Doppler assessment of all valves should be performed. Both atrioventricular valves should have biphasic flow patterns, and both semilunar valves should have a brisk upstroke with a narrow spectrum of normal velocities and no aliasing or increased velocity to suggest stenosis.

Aorta, Pulmonary Artery, and the Aortic and Ductal Arches

The relationship of the aorta and pulmonary outflow to the ventricles should be determined. The aorta and pulmonary artery arise from the left and right ventricles, respectively, and should cross over one another. Any relationship where the great vessels do not cross should prompt consideration of transposed great arteries and significant CHD.

The aortic arch, main and branch pulmonary arteries, and ductal arch should be assessed in multiple planes. In addition to the sagittal view, where the entirety of the aortic and ductal arches can be assessed, the three-vessel trachea view is particularly useful in assessing location, size, and flow pattern of the aortic and ductal arches. Arch sidedness can be determined from the three-vessel view; the usual arrangement being the aorta and ductus arteriosus coursing to the left as they pass in front of the trachea ( Fig. 70.2 ). Additionally, the three-vessel-trachea view is of particular utility in diagnosing aortic arch hypoplasia and/or ductus arteriosus abnormalities.

Figure 70.2, Normal three-vessel trachea view.

Prenatal Imaging: Timing and Indications

The optimal period for transabdominal imaging is 20 to 28 weeks' gestation, although transabdominal imaging at earlier gestations ages has been reported. Transvaginal transducers can be used to image the fetal heart as early as 8 weeks, with successful diagnosis of heart defects possible at 11 weeks. Although some particularly nuanced anatomic features are not detectable with early scanning, identification of single ventricle CHD and significant outflow abnormalities is feasible. Third-trimester imaging is frequently limited by less amniotic fluid relative to the size of the fetus, and the diminished likelihood of significant changes in fetal position further restricts available imaging planes.

Indications for fetal echocardiography based on maternal or fetal risk factors are extensive and expanding ( Box 70.1 ). The most common reasons for referral are a family history of CHD, fetal arrhythmia, maternal diabetes, and extracardiac abnormalities. The indication most predictive of cardiac disease is an abnormal four-chamber view on routine obstetric ultrasound, underscoring the importance of high-quality obstetric screening. Fetal arrhythmia, hydrops, and polyhydramnios are also important predictors of CHD. Equally important is an understanding of indications for which fetal echocardiography is not recommended ( Box 70.2 ); fetal echocardiography is a highly specialized examination and should be reserved for appropriate circumstances, as unnecessary fetal cardiac evaluations may generate family anxiety.

Box 70.1
Indications for Fetal Echocardiography

Indications With Higher Risk Profile (Estimated >2% Absolute Risk)

  • Maternal pregestational diabetes mellitus

  • Diabetes mellitus diagnosed in the first trimester

  • Maternal phenylketonuria (uncontrolled)

  • Maternal autoantibodies (SSA/SSB+)

  • Maternal medications

  • ACE inhibitors

  • Retinoic acid

  • NSAIDs in third trimester

  • Maternal first trimester rubella infection

  • Maternal infection with suspicion of fetal myocarditis

  • Assisted reproduction technology

  • CHD in first degree relative of fetus (maternal, paternal, or sibling with CHD)

  • First- or second-degree relative with disorder with Mendelian inheritance with CHD association

  • Fetal cardiac abnormality suspected on obstetrical ultrasound

  • Fetal extracardiac abnormality suspected on obstetrical ultrasound

  • Fetal karyotype abnormality

  • Fetal tachycardia or bradycardia, or frequent or persistent irregular heart rhythm

  • Fetal increased nuchal thickness >95% (≥3 mm)

  • Monochorionic twinning

  • Fetal hydrops or effusions

Indications With Lower Risk Profile (Estimated >1% but <2% Absolute Risk)

  • Maternal medications

    • Anticonvulsants

    • Lithium

    • Vitamin A

    • Selective serotonin reuptake inhibitors (only paroxetine)

    • NSAIDs in first/second trimester

  • CHD in second-degree relative of fetus

  • Fetal abnormality of the umbilical cord or placenta

  • Fetal intraabdominal venous anomaly

Box 70.2
Fetal Echocardiography Not Indicated (≤1% Risk)

  • Maternal gestational diabetes mellitus with HbA1c <6%

  • Maternal medications

    • Selective serotonin reuptake inhibitors (other than paroxetine)

    • Vitamin K agonists (Coumadin), although fetal survey is recommended

  • Maternal infection other than rubella with seroconversion only

  • Isolated CHD in a relative other than first or second degree

Evaluation for Specific Cardiac Defects

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here